We optimize the way you supply sites & depots.
Resupply optimization is more important than ever amid changing clinical trial needs and tightening budgets. Our drug supply experts optimize the way you supply sites and depots based on real-time drug availability and recruitment data, via established, industry-leading resupply algorithms. Clinical drug supply is about more than just logistics, and our experts are seeing a trend of 60% of on-site drug supply that's ultimately not used - that's 60% our industry can no longer afford! The Cenduit Drug Supply Center of Excellence has extensive experience delivering, simplifying, and optimizing drug supply plans to produce significant savings.
Our Drug Supply Center of Excellence will deliver, simplify & optimize your drug supply plans, resulting in significant savings.
Our Drug Supply Center of Excellence has extensive experience in delivering a variety of invaluable drug supply management services:
- Size and timing of packaging campaigns.
- Size and timing of depot shipment.
- Automated IRT site resupply strategy.
- Support sponsor to define optimal drug supply strategy.
- Daily checks confirming depots and sites are well stocked.
- Monthly overage check and drug forecasting report with actionable recommendations.
- Monthly review and adjustment of resupply strategy.
- Continuously monitor drug supply needs.
We'll help you save on supply service costs.
Cenduit Drug Supply Management Roadmap.
Cenduit Drug Supply Center of Excellence experts work closely with you to develop the optimal drug supply strategy prior to study and monitors your supply situation on a daily basis. This ensuresing drug gets to every patient on time while keeping the costs for drug overage and shipment to a minimum.
Empower Your Resupply Optimization Strategy.
Cenduit drug supply experts optimize the way your sites are supplied in real time based on drug availability and recruitment data. With industry-leading resupply algorithms, our team will work closely with you - enabling savings on shipment costs that are greater than the drug supply service costs.